相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PharmGKB summary: dopamine receptor D2
Huaiyu Mi et al.
PHARMACOGENETICS AND GENOMICS (2011)
Platelet aggregation pathway
Katrin Sangkuhl et al.
PHARMACOGENETICS AND GENOMICS (2011)
Pharmacogenomic biomarkers: new tools in current and future drug therapy
Sarah C. Sim et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups
Nita A. Limdi et al.
BLOOD (2010)
Emergency re-admissions to hospital due to adverse drug reactions within 1 year of the index admission
Emma C. Davies et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
The Pharmacogenomics of Membrane Transporters Project: Research at the Interface of Genomics and Transporter Pharmacology
D. L. Kroetz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI A Meta-analysis
Jessica L. Mega et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Using text to build semantic networks for pharmacogenomics
Adrien Coulet et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2010)
Clinical assessment incorporating a personal genome
Euan A. Ashley et al.
LANCET (2010)
Drug-induced liver injury: past, present and future
Ann K. Daly
PHARMACOGENOMICS (2010)
Teaching computers to read the pharmacogenomics literature ... so you don't have to
Yael Garten et al.
PHARMACOGENOMICS (2010)
Pharmspresso: a text mining tool for extraction of pharmacogenomic concepts and relationships from full text
Yael Garten et al.
BMC BIOINFORMATICS (2009)
Generating Genome-Scale Candidate Gene Lists for Pharmacogenomics
N. T. Hansen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes
Emma C. Davies et al.
PLOS ONE (2009)
Nomenclature for alleles of the cytochrome P450 oxidoreductase gene
Sarah C. Sim et al.
PHARMACOGENETICS AND GENOMICS (2009)
New feature: pathways and important genes from PharmGKB
Michel Elchelbaum et al.
PHARMACOGENETICS AND GENOMICS (2009)
Predicting drug side-effects by chemical systems biology
Nicholas P. Tatonetti et al.
GENOME BIOLOGY (2009)
Changes in consensus arylamine N-acetyltransferase gene nomenclature
David W. Hein et al.
PHARMACOGENETICS AND GENOMICS (2008)
Arylamine N-acetyltransferases: Structural and functional implications of polymorphisms
Edith Sim et al.
TOXICOLOGY (2008)
Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects
Magnus Ingelman-Sundberg et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Serious adverse drug events reported to the food and drug administration, 1998-2005
Thomas J. Moore et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily
PI Mackenzie et al.
PHARMACOGENETICS AND GENOMICS (2005)
Pharmacogenetics of antidepressants and antipsychotics:: the contribution of allelic variations to the phenotype of drug response
J Kirchheiner et al.
MOLECULAR PSYCHIATRY (2004)
Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future
M Ingelman-Sundberg
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Transporter database, TP-Search: A Web-accessible comprehensive database for research in pharmacokinetics of drugs
N Ozawa et al.
PHARMACEUTICAL RESEARCH (2004)
Genomic medicine - Inheritance and drug response.
R Weinshilboum
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Genetic susceptibility to adverse drug reactions
M Pirmohamed et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2001)
Clinical application of pharmacogenetics
BB Spear et al.
TRENDS IN MOLECULAR MEDICINE (2001)
Update on consensus arylamine N-acetyltransferase gene nomenclature
DW Hein et al.
PHARMACOGENETICS (2000)
分享论文
